Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats.
Explore this paper's citation graph
Summary
It is indicated that GLP-1-(7-36) amide significantly increases arterial blood pressure and heart rate and that these effects are not mediated through catecholamines.
- Type
- article
- Published
- 1994-03-01
- Cited by
- 208
- References
- 23
- OpenAlex
- https://openalex.org/W1831731874
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:10779542
Keywords
Blood pressure, Heart rate, Propranolol, Phentolamine, Internal medicine
References
- Characterization of glucagon-like peptide-1-(7-36)amide in the hypothalamus.
- Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut
- Glucagon gene expression in vertebrate brain.
- Autoradiographic localization of receptors for glucagon-like peptide-1 (7-36) amide in rat brain.
- Identification and characterization of glucagon‐like peptide‐1 7–36 amide‐binding sites in the rat brain and lung
- Regional circulatory effects of pancreatic glucagon
- Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.
- Human glucagon‐like peptides 1 and 2 activate rat brain adenylate cyclase
- Lipolytic action of glucagon-like peptides in isolated rat adipocytes.
- Hemodynamic Responses to Glucagon: An Experimental Study of Central, Visceral and Peripheral Effects
- Cardiac dose response relationship for intravenously infused glucagon in normal intact dogs and men.
- Renal catabolism of human glucagon-like peptides 1 and 2.
- Cardiorespiratory response patterns elicited by microinjections of neuropeptide Y in the nucleus tractus solitarius.
- Glucagon-induced changes in the action potential, contraction, and Na+-K+-ATPase of cardiac muscle.
- Characterization of high‐affinity receptors for truncated glucagon‐like peptide‐1 in rat gastric glands
- Coated charcoal immunoassay of insulin.
- Glucagon-like peptide-1 7-36: a physiological incretin in man.
- Glucagon: Its Enhancement of Cardiac Performance in the Cat and Dog and Persistence of its Inotropic Action Despite Beta‐Receptor Blockade with Propranolol
- Characterization of glucagon‐like peptide‐I(7–36)amide receptors of rat lung membranes by covalent cross‐linking
- Selective release of glutamine and glutamic acid produced by perfusion of GLP-1 (7-36) amide in the basal ganglia of the conscious rat.
Cited by
- Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats.
- Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
- Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system.
- GLP-1 CellBead therapy for the prevention of left ventricular dysfunction in pigs
- Impact of Weight-Loss Medications on the Cardiovascular System
- Preventing Flap Necrosis With Adrenomedullin and Glucagon-like Peptide-1.
- Insulin resistance, chronic heart failure and potential treatment
- Investigation of the haemodynamic effects of exenatide in healthy male subjects.
- Both stimulation of GLP‐1 receptors and inhibition of glycogenolysis additively contribute to a protective effect of oral miglitol against ischaemia‐reperfusion injury in rabbits
- Pleiotropic actions of the incretin hormones.
- Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development.
- Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials
- Studies on Incretins and Cardiovascular Function
- Possible involvement of GLP‐1(9–36) in the regional haemodynamic effects of GLP‐1(7–36) in conscious rats
- Die Wirkung des Dipeptidylpeptidase-4-Inhibitors Vildagliptin auf die Magenentleerung, die Glykämie und den Glukosestoffwechsel bei Patienten mit Diabetes mellitus Typ 2
- The incretin system in type 2 diabetes mellitus: cardiovascular effects
- Identificación de células enteroendocrinas productoras del peptido similar al glucagón tipo-1(glp-1) en intestinos de alpacas
- On endothelial function in type 2 diabetic patients with coronary artery disease
- Myokardiale Regeneration im Glukagon-like-peptide-1 Rezeptor knock out Mausmodell
- Glucagon-like peptide isolated from the eel intestine: effects on atrial beating.
Related papers
- Reversal of alpha-adrenoceptor blockade by propranolol in isolated rat pulmonary artery.
- Unexpected agonistic pressor effect of propranolol and angiotensin II in bilaterally nephrectomized rats.
- Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage.
- Effects of propranolol on intestinal microcirculation of normal and portal hypertensive rats.
- Effect of adrenergic blocking agents on peripheral noradrenaline induced thermoregulatory responses in the pigeon at heat
- Interaction of propranolol and phentolamine with ethanol in the rat.
- Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure.
- Biphasic pattern of hypersensitivity following acute propranolol withdrawal in normal subjects.
- Pharmacological studies with tiprenolol and propranolol in man.